Published in
Taylor and Francis Group, Journal of Dermatological Treatment, 1(33), p. 266-277, 2020
DOI: 10.1080/09546634.2020.1750550
Links
Tools
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials
Journal article published in 2020 by
S. Barbarot 
,
A. Wollenberg ,
J. I. Silverberg ,
M. Deleuran ,
G. Pellacani ,
J. C. Armario-Hita ,
Z. Chen,
B. Shumel,
L. Eckert,
A. Gadkari,
Y. Lu,
A. B. Rossi
,
A. Wollenberg ,
J. I. Silverberg ,
M. Deleuran ,
G. Pellacani ,
J. C. Armario-Hita ,
Z. Chen,
B. Shumel,
L. Eckert,
A. Gadkari,
Y. Lu,
A. B. Rossi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 